TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
ARA Life Science AB
Closing information (x1000 NOK)
| Closing information | 2023/04 | 2022/04 | 2021/04 |
| Turnover |
177
|
158
|
149 |
| Financial expenses |
0
|
0
|
1 |
| Earnings before taxes |
156
|
133
|
132 |
| EBITDA |
156
|
133
|
133 |
| Total assets |
306
|
280
|
291 |
| Current assets |
306
|
280
|
291 |
| Current liabilities |
75
|
77
|
82 |
| Equity capital |
231
|
203
|
209 |
| - share capital |
104
|
95
|
98 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2023/04 | 2022/04 | 2021/04 |
| Solvency |
75.5%
|
72.5%
|
71.8% |
| Turnover per employee |
88
|
79
|
74 |
| Profit as a percentage of turnover |
88.1%
|
84.2%
|
88.6% |
| Return on assets (ROA) |
51.0%
|
47.5%
|
45.7% |
| Current ratio |
408.0%
|
363.6%
|
354.9% |
| Return on equity (ROE) |
67.5%
|
65.5%
|
63.2% |
| Change turnover |
5
|
13
|
11 |
| Change turnover % |
3%
|
9%
|
8% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/04 | 2022/04 | 2021/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.